Drugs / Fluzone High Dose
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03312699 | Sep 2017 → Dec 2023 | hepatitis A virus infection, influenza, typhoid fever | Stanford University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fluzone High Dose | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03312699 ↗ |
| Modality | Vaccine | “High Dose IIV3 vaccine” NCT03312699 ↗ |
| Route | Intramuscular | “by IM injection into the deltoid muscle” NCT03312699 ↗ |